In a normal physiological context, replicative senescence serves as a crucial defense mechanism to suppress cancer development. By halting the proliferation of potentially pre-cancerous cells, senescence prevents the accumulation of genetic mutations that could lead to malignancy. However, cancer cells often find ways to bypass this barrier. One common strategy is the activation of the enzyme telomerase, which elongates telomeres and allows cells to continue dividing indefinitely.
